137 related articles for article (PubMed ID: 38549284)
1. Pseudoacromegaly-A challenging entity in the endocrine clinic: A systematic review.
Marques P; Sapinho I; Korbonits M
Clin Endocrinol (Oxf); 2024 Jun; 100(6):542-557. PubMed ID: 38549284
[TBL] [Abstract][Full Text] [Related]
2. Pseudoacromegaly.
Marques P; Korbonits M
Front Neuroendocrinol; 2019 Jan; 52():113-143. PubMed ID: 30448536
[TBL] [Abstract][Full Text] [Related]
3. Pseudoacromegaly Associated with Non-Functioning Pituitary Adenoma.
Alotaibi A; Habib A; Osman M; Alzahrani K; Alzahrani F
Eur J Case Rep Intern Med; 2020; 7(12):001950. PubMed ID: 33313006
[TBL] [Abstract][Full Text] [Related]
4. Approach to the Patient With Pseudoacromegaly.
Marques P; Korbonits M
J Clin Endocrinol Metab; 2022 May; 107(6):1767-1788. PubMed ID: 34792134
[TBL] [Abstract][Full Text] [Related]
5. Insulin-mediated "pseudoacromegaly".
Sam AH; Tan T; Meeran K
Hormones (Athens); 2011; 10(2):156-61. PubMed ID: 21724541
[TBL] [Abstract][Full Text] [Related]
6. The utility of oral glucose tolerance testing for diagnosis and assessment of treatment outcomes in 166 patients with acromegaly.
Carmichael JD; Bonert VS; Mirocha JM; Melmed S
J Clin Endocrinol Metab; 2009 Feb; 94(2):523-7. PubMed ID: 19033371
[TBL] [Abstract][Full Text] [Related]
7. Pachydermoperiostosis: a rare mimicker of acromegaly.
Abdullah NRA; Jason WLC; Nasruddin AB
Endocrinol Diabetes Metab Case Rep; 2017; 2017():. PubMed ID: 28567291
[TBL] [Abstract][Full Text] [Related]
8. Insulin resistance and pseudoacromegaly: A case report.
Moradi L; Amiri F; Shahbazian H
Diabetes Metab Syndr; 2019; 13(2):901-903. PubMed ID: 31336543
[TBL] [Abstract][Full Text] [Related]
9. Dynamic tests and basal values for defining active acromegaly.
Tzanela M
Neuroendocrinology; 2006; 83(3-4):200-4. PubMed ID: 17047383
[TBL] [Abstract][Full Text] [Related]
10. Elevated IGF-1 with GH suppression after an oral glucose overload: incipient acromegaly or false-positive IGF-1?
Rosario PW; Calsolari MR
Arch Endocrinol Metab; 2016; 60(6):510-514. PubMed ID: 27982199
[TBL] [Abstract][Full Text] [Related]
11. Spontaneous remission of acromegaly or gigantism due to subclinical apoplexy of pituitary growth hormone adenoma.
Wang XL; Dou JT; Lü ZH; Zhong WW; Ba JM; Jin D; Lu JM; Pan CY; Mu YM
Chin Med J (Engl); 2011 Nov; 124(22):3820-3. PubMed ID: 22340248
[TBL] [Abstract][Full Text] [Related]
12. Hormonal diagnosis of GH hypersecretory states.
Grottoli S; Gasco V; Ragazzoni F; Ghigo E
J Endocrinol Invest; 2003; 26(10 Suppl):27-35. PubMed ID: 15497657
[TBL] [Abstract][Full Text] [Related]
13. Preoperative growth hormone response to thyrotropin-releasing hormone and oral glucose tolerance test in acromegaly: a retrospective evaluation of 50 patients.
De Marinis L; Mancini A; Bianchi A; Gentilella R; Valle D; Giampietro A; Zuppi P; Anile C; Maira G; Giustina A
Metabolism; 2002 May; 51(5):616-21. PubMed ID: 11979395
[TBL] [Abstract][Full Text] [Related]
14. Impact of tumor characteristics and pre- and postoperative hormone levels on hormonal remission following endoscopic transsphenoidal surgery in patients with acromegaly.
Cardinal T; Rutkowski MJ; Micko A; Shiroishi M; Jason Liu CS; Wrobel B; Carmichael J; Zada G
Neurosurg Focus; 2020 Jun; 48(6):E10. PubMed ID: 32480366
[TBL] [Abstract][Full Text] [Related]
15. Laboratory investigation of acromegaly: is basal or random GH > 0.4 µg/L in the presence of normal serum IGF-1 an important result?
Rosario PW; Calsolari MR
Arch Endocrinol Metab; 2015 Feb; 59(1):54-8. PubMed ID: 25926115
[TBL] [Abstract][Full Text] [Related]
16. Ghrelin test for the assessment of GH status in successfully treated patients with acromegaly.
Pekic S; Doknic M; Miljic D; Joksimovic M; Glodic J; Djurovic M; Dieguez C; Casanueva F; Popovic V
Eur J Endocrinol; 2006 May; 154(5):659-66. PubMed ID: 16645012
[TBL] [Abstract][Full Text] [Related]
17. Caloric restriction as a possible pitfall for persistent acromegaly follow-up - case report.
Martins AF; Santos M; Rosário F
BMC Endocr Disord; 2023 Mar; 23(1):68. PubMed ID: 36973824
[TBL] [Abstract][Full Text] [Related]
18. Clinical, hormonal and magnetic resonance imaging (MRI) predictors of transsphenoidal surgery outcome in acromegaly.
Bourdelot A; Coste J; Hazebroucq V; Gaillard S; Cazabat L; Bertagna X; Bertherat J
Eur J Endocrinol; 2004 Jun; 150(6):763-71. PubMed ID: 15191345
[TBL] [Abstract][Full Text] [Related]
19. Acromegaly.
Scacchi M; Cavagnini F
Pituitary; 2006; 9(4):297-303. PubMed ID: 17077948
[TBL] [Abstract][Full Text] [Related]
20. Cardiac and metabolic effects of chronic growth hormone and insulin-like growth factor I excess in young adults with pituitary gigantism.
Bondanelli M; Bonadonna S; Ambrosio MR; Doga M; Gola M; Onofri A; Zatelli MC; Giustina A; degli Uberti EC
Metabolism; 2005 Sep; 54(9):1174-80. PubMed ID: 16125529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]